Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Immuno-PDT, verteporfin (Visudyne) (BPD-MA)
print preview
bookmark
share with colleague
General Information
Company
Valeant Pharmaceuticals International Inc.
Description
Light-activated benzoporphyrin derivative used in photodynamic therapy (PDT)
Molecular Target
Not available
Mechanism of Action
Photodynamic therapy
Latest Stage of Development
Marketed
Indication
Choroidal neovascularization (CNV)
Partner
Novartis AG
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy